Last reviewed · How we verify

NCT03165383: TAP

The Analgesic Efficacy of Ultrasound Guided Transversus Abdominal Plane Block After Abdominal Cancer Surgeries

Completed NA Last updated 24 May 2017
What this trial tests

NA trial testing Bupivacaine (Transversus Abdominis Plane Block) in Abdominal Cancer in 60 participants. Completed in 20 August 2014.

Timeline
11 February 2013
Primary endpoint
10 July 2014
20 August 2014

Quick facts

Lead sponsorRajiv Gandhi Cancer Institute & Research Center, India
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date11 February 2013
Primary completion10 July 2014
Estimated completion20 August 2014

Drugs / interventions tested

Conditions studied

Sponsor

Rajiv Gandhi Cancer Institute & Research Center, India

Who can join

Adults 18 to 65, any sex, with Abdominal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Effective postoperative pain control results in decreased cardiac and pulmonary complications, patient satisfaction and early mobilization. A prospective, randomized comparative study was done of analgesic efficacy, opioid requirement and side effects in patients undergoing lower abdominal cancer surgeries. In Study Group Ultrasound guided Transversus Abdominis Plane (TAP) block was given and control Group no TAP block was given. Patient controlled analgesia (PCA) with intravenous morphine was given to both group patients, and total good PCA demands in both the groups was studied.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Abdominal Cancer

Currently open trials in the same condition.

Other Rajiv Gandhi Cancer Institute & Research Center, India trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03165383.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing